Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Finished Goods (2022 - 2025)

Neuroone Medical Technologies' Finished Goods history spans 4 years, with the latest figure at $518209.0 for Q4 2025.

  • For Q4 2025, Finished Goods fell 41.11% year-over-year to $518209.0; the TTM value through Dec 2025 reached $518209.0, down 41.11%, while the annual FY2025 figure was $1.2 million, 21.75% down from the prior year.
  • Finished Goods reached $518209.0 in Q4 2025 per NMTC's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $1.6 million in Q3 2024 to a low of $73968.0 in Q3 2022.
  • Average Finished Goods over 4 years is $664841.0, with a median of $624486.5 recorded in 2024.
  • Peak YoY movement for Finished Goods: surged 768.35% in 2024, then crashed 41.11% in 2025.
  • A 4-year view of Finished Goods shows it stood at $73968.0 in 2022, then surged by 143.47% to $180092.0 in 2023, then soared by 388.62% to $879966.0 in 2024, then plummeted by 41.11% to $518209.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Finished Goods are $518209.0 (Q4 2025), $1.2 million (Q3 2025), and $775950.0 (Q2 2025).